These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 400749)

  • 21. Use of saralasin to detect renovascular hypertension in childhood.
    Gillespie L; Ehrlich RM; Marks LS; Maxwell MH; Kaufman JJ
    Urology; 1980 Nov; 16(5):453-6. PubMed ID: 7003900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of saralasin on normal blood pressure and on reno-vascular hypertension (author's transl)].
    Beckerhoff R; Vetter W; Furrer J; Nussberger J; Schmied U; Siegenthaler W
    Dtsch Med Wochenschr; 1976 Mar; 101(11):398-401. PubMed ID: 1253700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of renovascular hypertension with angiotensin II blockade.
    Baer L; Parra-Carrilo JZ; Radichevich I; Williams GS
    Ann Intern Med; 1977 Mar; 86(3):257-60. PubMed ID: 842983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Saralasin test as a diagnostic and prognostic aid in renovascular hypertensive patients subjected to renal operation.
    Poutasse EF; Gonzalez-Serva L; Wendelken JR; Franz JP
    J Urol; 1980 Mar; 123(3):306-10. PubMed ID: 6987415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Significance of the saralasin infusion test in the diagnosis of arterial hypertension].
    Glorioso N; Madeddu P; Dessì-Fulgheri P; Meloni F; Palermo M; Fiori C; Rappelli A
    Boll Soc Ital Cardiol; 1980; 25(9):1035-46. PubMed ID: 7025868
    [No Abstract]   [Full Text] [Related]  

  • 26. Laboratory tests in the evaluation of renal hypertension.
    Vaughan ED
    Urol Clin North Am; 1979 Oct; 6(3):485-502. PubMed ID: 388789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Saralasin testing for renin-dependent hypertension.
    Weber MA
    Arch Intern Med; 1979 Jan; 139(1):93-5. PubMed ID: 760691
    [No Abstract]   [Full Text] [Related]  

  • 28. Angiotensin blockade in renovascular hypertension: a controlled, prospective study.
    Marks LS; Maxwell MH; Gross C; Waks U; Kaufman JJ
    Br J Urol; 1977 Jun; 49(3):181-8. PubMed ID: 334316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF; Russell GI; Swales JD; Thurston H
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of saralasin in end-stage renal disease.
    Fadem SZ; Lifschitz MD
    Kidney Int Suppl; 1979 Mar; (9):S93-100. PubMed ID: 289869
    [No Abstract]   [Full Text] [Related]  

  • 31. Renovascular disease and saralasin tests.
    Ann Intern Med; 1977 Dec; 87(6):790-1. PubMed ID: 931217
    [No Abstract]   [Full Text] [Related]  

  • 32. The use of an angiotensin II antagonist (saralasin) as an adjunct during renal vein catheterization.
    Ibsen H; Giese J; Rabøl A; Kappelgaard AM
    Scand J Clin Lab Invest; 1980 Apr; 40(2):115-20. PubMed ID: 7020064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response of chronic renovascular hypertension to surgical correction or prolonged blockade of the renin-angiotensin system by two inhibitors in the rat.
    Thurston H; Bing RF; Marks ES; Swales JD
    Clin Sci (Lond); 1980 Jan; 58(1):15-20. PubMed ID: 6986225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Saralasin infusion in renovascular and essential hypertension.
    Thien T; Hoefnagels WH
    Neth J Med; 1980; 23(2):68-73. PubMed ID: 6990282
    [No Abstract]   [Full Text] [Related]  

  • 35. Sympathetic nerve hyperactivity in high-renin hypertension effects of saralasin infusion.
    DeQuattro V; Barbour BH; Campese V; Finck EJ; Miano L; Esler M
    Mayo Clin Proc; 1977 Jun; 52(6):369-73. PubMed ID: 865132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between the renin-angiotensin and beta adrenergic nervous systems in drinking and pressor responses after renal artery constriction.
    Atkinson J; Lüthi P; Péra-Bally R; Peters-Haefeli L
    J Pharmacol Exp Ther; 1982 May; 221(2):453-60. PubMed ID: 6281416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humoral and neurogenic factors in two-kidney renovascular hypertension.
    de la Riva IJ; Basso N; Kurnjek ML; Taquini AC
    Arch Int Physiol Biochim; 1980 May; 88(2):137-46. PubMed ID: 6159837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
    Zawada ET; Stinson J; Ramirez G
    Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of angiotensin antagonists in experimental and human renovascular hypertension.
    Maxwell MH
    Adv Nephrol Necker Hosp; 1979; 8():297-319. PubMed ID: 115245
    [No Abstract]   [Full Text] [Related]  

  • 40. Renin, sodium, and vasodepressor response to saralasin in renovascular and essential hypertension.
    Marks LS; Maxwell MH; Kaufman JJ
    Ann Intern Med; 1977 Aug; 87(2):176-82. PubMed ID: 889198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.